Acadia Pharmaceuticals | ACAD - الأصول

سعر السهم
21.85
التغيير اليومي
-0.60 -2.67%
شهريا
-1.58%
سنويا
46.55%
Q2 التوقعات
21.49




الأصول تغيير تاريخ
Acadia Pharmaceuticals USD 1.56B 233.42M 2025-12
ALKERMES USD 2.49B 157.48M 2025-12
Alnylam Pharmaceuticals USD 5.13B 163.22M 2026-03
Biogen USD 29.48B 43.6M 2026-03
BioMarin Pharmaceutical USD 7.59B 20.85M 2025-12
Bristol-Myers Squibb USD 86.48B 3.56B 2026-03
Cara Therapeutics USD 39.02M 4.73M 2025-09
Corcept Therapeutics USD 814.88M 21.77M 2026-03
Cytokinetics USD 1.42B 12.02M 2025-12
Eisai JPY 1.49T 48.22B 2025-12
Eli Lilly USD 116.58B 4.1B 2026-03
Incyte USD 7.34B 381.14M 2026-03
J&J USD 200.89B 1.68B 2026-03
Moderna USD 11.49B 850M 2026-03
Neurocrine Biosciences USD 4.63B 365.8M 2025-12
Pfizer USD 208.73B 2.64B 2025-09
Prothena USD 326.8M 25.82M 2025-12
PTC Therapeutics USD 2.9B 255.07M 2025-12
Sarepta Therapeutics USD 3.35B 143.73M 2025-12
Ultragenyx Pharmaceutical USD 1.53B 341.56M 2025-12
Vanda Pharmaceuticals USD 488.95M 112.19M 2025-12
Vertex Pharmaceuticals USD 25.64B 780.7M 2025-12